Patents by Inventor Lisa Abegglen

Lisa Abegglen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016890
    Abstract: The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.
    Type: Application
    Filed: October 3, 2023
    Publication date: January 18, 2024
    Inventors: Joshua Schiffman, Avi Schroeder, Lisa Abegglen
  • Patent number: 11833188
    Abstract: The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: December 5, 2023
    Assignees: UNIVERSITY OF UTAH RESEARCH FOUNDATION, TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Joshua Schiffman, Avi Schroeder, Lisa Abegglen
  • Publication number: 20200368316
    Abstract: The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.
    Type: Application
    Filed: June 5, 2020
    Publication date: November 26, 2020
    Inventors: Joshua Schiffman, Avi Schroeder, Lisa Abegglen
  • Patent number: 10709761
    Abstract: The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: July 14, 2020
    Assignees: UNIVERSITY OF UTAH RESEARCH FOUNDATION, TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Joshua Schiffman, Avi Schroeder, Lisa Abegglen
  • Publication number: 20190070259
    Abstract: The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.
    Type: Application
    Filed: October 7, 2016
    Publication date: March 7, 2019
    Inventors: Joshua Schiffman, Avi Schroeder, Lisa Abegglen